Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Daily Feeds
Calendars
Economic Indicators
Class Actions
Calculators
Education
About Us
Working with TipRanks
Follow Us
Phreesia (PHR)
NYSE:PHR
Holding PHR?
Track your performance easily
PHR Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$17.07 - $29.16
Previous Close$24.94
Volume352.05K
Average Volume (3M)406.60K
Market Cap
$1.45B
Enterprise Value$1.39B
Total Cash (Recent Filing)$81.74M
Total Debt (Recent Filing)$21.02M
Price to Earnings (P/E)―
Beta2.55
Next Earnings
Mar 26, 2025EPS Estimate
-$0.15Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-1.47
Shares Outstanding58,124,082
10 Day Avg. Volume553,328
30 Day Avg. Volume406,604
Standard Deviation0.17
R-Squared0.10
Alpha-0.00343
Financial Highlights & Ratios
Price to Book (P/B)5.69
Price to Sales (P/S)3.58
Price to Cash Flow (P/CF)62.70
P/FCF Ratio226.10
Enterprise Value/Market CapN/A
Enterprise Value/Revenue3.43
Enterprise Value/Gross Profit5.98
Enterprise Value/Ebitda-27.46
Forecast
1Y Price Target
$29.75Price Target Upside16.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering9
Phreesia News
Bulls Say, Bears Say
Bulls Say
EBITDA PerformancePhreesia's Network Solutions is driving EBITDA outperformance with favorable guidance for upcoming fiscal years.
Market PositionPhreesia has a strong market position, facilitating more than 150 million visits, or over 10% of patient visits in the U.S., with over 100 pharmaceutical brands including all of the top 10 global pharmaceutical companies as customers.
Product InnovationPhreesia's new pharmacy-related product aims to drive greater medication adherence, complementing existing offerings and boosting revenue growth opportunities.
Bears Say
Financial GuidanceThe clearinghouse client wind-down continues to mute the topline, causing the company to tighten its FY25 revenue range and lower the midpoint of its adjusted EBITDA guidance.
Investment ReturnsRecent investments, such as the Patient Activation Measure or Phreesia OnCall service, are failing to deliver return on investment, questioning the effectiveness of strategic spending.
Revenue GrowthPhreesia's revenue growth is moderating, with subscription growth and revenue guidance falling short of estimates, leading to reduced confidence in future performance.
---
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
PHR FAQ
What was Phreesia’s price range in the past 12 months?
Phreesia lowest stock price was $17.07 and its highest was $29.16 in the past 12 months.
What is Phreesia’s market cap?
Currently, no data Available
When is Phreesia’s upcoming earnings report date?
Phreesia’s upcoming earnings report date is Mar 26, 2025 which is in 95 days.
How were Phreesia’s earnings last quarter?
Phreesia released its earnings results on Dec 09, 2024. The company reported -$0.25 earnings per share for the quarter, missing the consensus estimate of -$0.237 by -$0.013.
Is Phreesia overvalued?
According to Wall Street analysts Phreesia’s price is currently Undervalued.
Does Phreesia pay dividends?
Phreesia does not currently pay dividends.
What is Phreesia’s EPS estimate?
Phreesia’s EPS estimate is -$0.15.
How many shares outstanding does Phreesia have?
Phreesia has 58,124,080 shares outstanding.
What happened to Phreesia’s price movement after its last earnings report?
Phreesia reported an EPS of -$0.25 in its last earnings report, missing expectations of -$0.237. Following the earnings report the stock price went up 11.604%.
Which hedge fund is a major shareholder of Phreesia?
Among the largest hedge funds holding Phreesia’s share is Deerfield Management Company, LP. It holds Phreesia’s shares valued at 12M.
---
Phreesia Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$29.75 (16.03% Upside)
$29.75 (16.03% Upside)
Blogger Sentiment
Bullish
PHR Sentiment 100%
Sector Average 70%
Sector Average 70%
Hedge Fund Trend
Increased
By 212.8K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $212.1K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▲ 0.9%
Last 30 Days ▲ 5.9%
Last 30 Days ▲ 5.9%
Technicals
SMA
Negative
20 days / 200 days
Momentum
18.59%
12-Months-Change
Fundamentals
Return on Equity
-31.89%
Trailing 12-Months
Asset Growth
0.28%
Trailing 12-Months
Company Description
Phreesia
Phreesia, Inc. provides patient check-in solutions for medical practices. It provides solutions that transform the healthcare experience by engaging patients in their care and enabling healthcare provider organizations to optimize operational efficiency, improve profitability and enhance clinical care. Through the SaaS-based Phreesia Platform the company offers healthcare provider organizations a robust suite of solutions to manage the patient intake process and a payments solution for secure processing of patient payments. Its platform also provides life sciences companies with an engagement channel for targeted and direct communication with patients. Phreesia was founded by Chaim Indig and Evan Roberts in January 2005 and is headquartered in New York, NY.
---
PHR Company Deck
---
PHR Earnings Call
Q3 2024
0:00 / 0:00
---
PHR Revenue Breakdown
45.91% Subscription and related services
27.90% Payment processing fees
26.19% Network solutions
---
PHR Stock 12 Month Forecast
Average Price Target
$29.75
▲(16.03% Upside)
Technical Analysis
Best Analysts Covering PHR
1 Year
1 Year Success Rate
6/11 ratings generated profit
1 Year Average Return
-6.28%
reiterated a buy rating 3 months ago
Copying Anne Samuel's trades and holding each position for 1 Year would result in 54.55% of your transactions generating a profit, with an average return of -6.28% per trade.
---